Oral thin film with high active agent loading
The present invention relates to an oral thin film comprising at least one cellulose derivative and at least one pharmaceutically active agent, the at least one pharmaceutically active agent having a water solubility of at most 50 g/L at 20° C. and a pH of 6 to 7 and being contained in the oral thin film in an amount of at least 20 wt. % in relation to the total weight of the oral thin film, and to a method for production of said oral thin film, and use thereof as a medicament.
1 . An oral thin film comprising at least one cellulose derivative and at least one pharmaceutically active agent, characterised in that the at least one pharmaceutically active agent comprises ketamine or a pharmaceutically acceptable salt thereof and is contained in the oral thin film in an amount of at least approximately 20 wt. % in relation to the total weight of the oral thin film and wherein the oral thin film has a disintegration time of less than 41 seconds and wherein the at least one cellulose derivative comprises a mixture of two hydroxypropyl methylcelluloses having different viscosities.
2 . The oral thin film according to claim 1 , characterised in that the at least one cellulose derivative is contained in the oral thin film in an amount of approximately 5 to 80 wt. % in relation to the total weight of the oral thin film.
3 . The oral thin film according to claim 1 , characterised in that the at least one cellulose derivative comprises a water-soluble and/or water-swellable cellulose derivative.
4 . The oral thin film according to claim 1 , characterised in that the at least one pharmaceutically active agent has a molecular weight of at most approximately 1000 g/mol.
5 . The oral thin film according to claim 1 , characterised in that the at least one pharmaceutically active agent comprises(S) ketamine or a pharmaceutically acceptable salt thereof.
6 . The oral thin film according to claim 1 , characterised in that the oral thin film further comprises at least one auxiliary selected from the group comprising colouring agents, flavourings, sweeteners, taste-masking agents, emulsifiers, enhancers, pH regulators, humectants, preservatives and/or antioxidants.
7 . The oral thin film according to claim 1 , characterised in that the mass per unit area of the oral thin film is approximately 50 to 300 g/m 2 .
8 . A medicament for reducing a risk of suicide comprising the oral thin film of claim 1 .
9 . The oral thin film according to claim 1 , characterised in that the at least one pharmaceutically active agent has a molecular weight of at most approximately 500 g/mol.
10 . The oral thin film according to claim 1 wherein the ratio of a lower viscosity hydroxypropyl methylcellulose to a higher viscosity hydroxypropyl methylcellulose is approximately 1:5 to 5:1.
11 . The oral thin film according to claim 1 wherein the pharmaceutically active agent is contained in an amount of at least 40 wt. %.
12 . The oral thin film according to claim 1 wherein the at least one cellulose derivative is contained in the oral thin film in an amount of approximately 20 to 60 wt. %.
13 . The oral thin film according to claim 6 wherein the auxiliary is contained in the oral thin film in an amount of approximately 0.1 to 10 wt. %.
14 . The oral thin film according to claim 1 wherein the at least one hydroxypropyl methylcellulose has a viscosity of approximately 1 to 5 mPas.
15 . The oral thin film according to claim 14 wherein the other at least one hydroxypropyl methylcellulose has a viscosity of approximately 40 to 60 mPas.
16 . The oral thin film according to claim 15 wherein the at least one hydroxypropyl methylcellulose comprises about 35 to 40 wt. %.
17 . The oral thin film according to claim 16 wherein the other at least one hydroxypropyl methylcellulose comprises about 5 to 15 wt. %.
18 . The oral thin film according to claim 17 including about 40 to 45 wt. %. (S) Ketamine.